-
Signature
-
Michael J. Farrell, Chief Executive Officer
-
Stock symbol
-
RMD
-
Transactions as of
-
Apr 17, 2023
-
Transactions value $
-
-$944,738
-
Form type
-
4
-
Date filed
-
4/18/2023, 04:59 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$328K |
+5.68K |
+1.3% |
$57.76 |
443K |
Apr 17, 2023 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$1.27M |
-5.68K |
-1.28% |
$224.23 |
437K |
Apr 17, 2023 |
Direct |
F1, F2 |
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
4.09K |
Apr 17, 2023 |
Lisette and Michael Farrell Family Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-5.68K |
-11.61% |
$0.00 |
43.2K |
Apr 17, 2023 |
ResMed Common Stock |
5.68K |
$57.76 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: